The Cigna Group (NYSE:CI) Posts Quarterly Earnings Results, Misses Expectations By $1.20 EPS

The Cigna Group (NYSE:CI) released its quarterly earnings results on Thursday. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20), RTT News reports. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. During the same period in the previous year, the business posted $6.79 EPS. The Cigna Group updated its FY 2025 guidance to 29.500- EPS.

The Cigna Group Price Performance

Shares of NYSE CI opened at $293.99 on Friday. The company has a market capitalization of $81.77 billion, a price-to-earnings ratio of 27.73, a price-to-earnings-growth ratio of 0.82 and a beta of 0.54. The business has a 50 day simple moving average of $294.40 and a 200-day simple moving average of $324.43. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a twelve month low of $262.03 and a twelve month high of $370.83.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $6.04 annualized dividend and a dividend yield of 2.05%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is presently 52.83%.

Analyst Ratings Changes

Several analysts have recently weighed in on CI shares. Raymond James reaffirmed a “strong-buy” rating and issued a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a report on Friday. Piper Sandler restated an “overweight” rating and set a $394.00 target price (up from $392.00) on shares of The Cigna Group in a research report on Tuesday, November 5th. Barclays decreased their price objective on shares of The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday. Truist Financial dropped their price objective on The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Cantor Fitzgerald reduced their target price on shares of The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Friday. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $380.27.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.